Tixagevimab-cilgavimab reduced risk for severe COVID-19 progression in patients with hematologic malignancies on anti-CD20 therapy during the early Omicron era.

The following is a summary of “60-day mortality and the role of SARS-CoV-2 in hospital admissions of immunocompromised patients during later Omicron period: a population-based study in Sweden,” ...

Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...

The Conversationalist dives into the debate on Greek life, exploring both its positive impact and its controversies. Gen Z voices discuss the role of fraternities and sororities in campus culture, ...

Compared with placebo, fostamatinib did not increase the number of oxygen-free days among adults hospitalized with COVID-19 and hypoxemia.

A Weill Cornell Medicine-Qatar study found that SARS-CoV-2 evolved from prioritizing transmission to evading immunity after the Omicron variant emerged. Before Omicron, natural immunity from prior ...

A new study from researchers at Weill Cornell Medicine-Qatar (WCM-Q) reveals how the SARS-CoV-2 virus evolved from initially ...

Two MSU sororities hosted their 18th annual Biennial Beautillion where they awarded two students with scholarships.

Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.

Here's what you need to know about the Foy-ODK Sportsmanship Trophy before Saturday's Alabama men's basketball game vs Auburn ...

Minnesota continues to have low rates of new COVID-19 infections, but the cases that are being diagnosed are increasingly caused by the latest version of the highly-contagious omicron variant.

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...